R. Menendez (Valencia, Spain), G. Dimopoulos (Athens, Greece)
Outbreak of human metapneumovirus infection in hospitalized adult patients
C. C. Tu, L. K. Chen, Y. S. Lee (Taichung, Hualien, Taiwan, Province Of China)
|  |
Are antibiotics effective for influenza-like illness? A prospective survey at fever clinic in Beijing, China
B. Cao, R. Li, Y. Liu, Z. Cao, J. Lu, C. Wang (Beijing, China)
| |
Detection of RSV antigens in non-presenting in adult lung cells
K. Plant, L. Hobson, M. Everard (Sheffield, United Kingdom)
| |
Spectrum of bacterial and viral pathogens of infectious exacerbation of COPD
O. Byalyk (Kiev, Ukraine)
| |
Respiratory viruses in the upper airways in non-allergic late-onset asthma
O. Schetchikova, S. Sobchenko, N. Yakovleva (Saint-Petersburg, Russian Federation)
| |
Role of respiratory infection in exacerbations of atopic asthma
G. Khaptkhaeva, A. Pustovalov, G. Tkachov, N. Kolganova, K. Zykov, A. Chuchalin (Moscow, Russian Federation)
| |
Chlamydophila pneumoniae and mycoplasma pneumoniae infection of airways and exacerbations of bronchoobstructive diseases
S. A. Kasimtseva, I. E. Stepanyan, O. V. Lovacheva (Moscow, Russian Federation)
| |
Chlamydophila pneumoniae and mycoplasma pneumoniae infection of airways in patients with bronchoobstructive diseases
S. A. Kasimtseva, I. E. Stepanyan, O. V. Lovacheva (Moscow, Russian Federation)
| |
Comparison of two enzyme linked immunosorbent assays for diagnosis of Chlamydia pneumoniae infection
M. Huebner, B. Luttenberger, C. Koidl, E. Daghofer, E. Marth (Graz, Austria)
|  |
Assessment of the treatment of ambulatory patients with respiratory infections
P. Nikolova, Y. Ivanov, P. Pavlov, T. Popova (Pleven, Bulgaria)
| |
Initial hospital management of community acquired pneumonia on the Isle of Man
M. Murthy, K. Win, R. Jones (Douglas, Isle of Man, United Kingdom)
| |
Community acquired pneumonia in patients with neuromuscular disorders. Severity assessment and outcome
I. Buha, S. Raljevic, B. Bulajic, M. Vukcevic, T. Radosavljevic (Belgrade, Serbia And Montenegro)
| |
Community-acquired pneumonia due to streptococcus pneumoniae in hospitalized patients – mortality predictors
S. Figueiredo, A. P. Vaz, C. Damas, J. Bento, M. D. Pinheiro, A. Amorim (Oporto, Portugal)
| |
Management of community acquired pneumonia
D. Damodaran, D. Christidis, K. Santhanakrishnan, F. Zaman, E. N. Ramamoorthy (Blackburn, Lancashire, United Kingdom; Madras, India)
| |
Monotherapy with β-lactamic antibiotics or macrolides vs their combination for the treatment of community acquired pneumonia (CAP)
A. Kosma, E. Kosma, P. Stefanopoulou, K. Kazanas, E. Kalaitzidou, N. Galanis (Thessaloniki, Greece)
| |
Immunoglobulin G antibodies to pneumococcal surface protein A (PspA) families in serum of adults with pneumococcal community-acquired pneumonia in China
Q. Ma, Q. Zhang, X. Zeng, C. Wang (Chongqing, China)
| |
Penicillin-resistant streptococcus pneumoniae is a rare etiology of community-acquired pneumonia requiring hospitalization: results from the CAPO international cohort study
M. Mirsaeidi, P. Peyrani, A. Diaz Fuenzalida, J. Gonzalez, L. Marzoratti, I. Toala, L. Rivero, J. Ramirez, The CAPO Investigators (Louisville, KY, United States Of America; Santiago, Chile; Buenos Aires, Tucuman, Argentina)
| |
Penicillin-resistance in Streptococcus pneumoniae isolates among adults with community-acquired pneumonia in the region of Tarragona, Spain
I. Hospital-Guardiola, A. Vila-Corcoles, I. Guinea-Oruechevarria, X. Cliville-Guasch, X. Raga-Luria, D. Rovira-Veciana (Tarragona, Spain)
| |
Therapeutic regimens in community acquired pneumonia (CAP): association with patients characteristics and outcomes
A. Kosma, E. Kosma, R. Vasilika, E. Kaimakamis, S. Penelope, S. Tryfon, N. Galanis (Thessaloniki, Greece)
| |